当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3244197
已选条件
-
T28824SNX0723
SNX0723 is a potent Hsp90 Inhibitor with anti-Plasmodium activity. SNX0723 shows high binding affinity for HsHsp90 and PfHsp90 with Kis of 4.4 and 47 nM, respectively. SNX0723 inhibits liver-stage P. berghei ANKA parasites with the EC50 of 3.3 μM.
价 格:¥电议型 号:T28824产 地:中国大陆
-
T6341PF04929113PF-04929113;SNX-5422;PF 04929113
SNX-5422 is a synthetic, novel, small molecule Hsp90 Inhibitor. As an oral formulation that demonstrates strong efficacy and tolerability, SNX-5422 is positioned as a breakthrough therapy with broad applicability across a wide range of cancers.
价 格:¥电议型 号:T6341产 地:中国大陆
-
T6305SNX2112SNX 2112;PF 04928473;SNX-2112
SNX-2112 is an orally active Hsp90 inhibitor, with a Kd of 16 nM.
价 格:¥电议型 号:T6305产 地:中国大陆
-
T4342PF-04929113 MesylatePF-04929113 (Mesylate);SNX-5422 Mesylate
PF-04929113 Mesylate, a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37 nM).
价 格:¥电议型 号:T4342产 地:中国大陆
-
T6305SNX-2112SNX-2112,SNX2112,SNX 2112
SNX-2112 is an orally active Hsp90 inhibitor, with a Kd of 16 nM.
价 格:¥电议型 号:T6305产 地:美洲
-
T81137SNX7886;化合物 SNX7886SNX7886
SNX7886 is a potent PROTAC (proteolysis-targeting chimera) that effectively degrades CDK8 and CDK19, achieving 90% degradation of CDK8 and 80% degradation of CDK19 in 293 cells [1].
价 格:¥电议型 号:T81137产 地:中国大陆
-
T80443ω-Conotoxin MVIID;化合物 ω-Conotoxin MVIIDSNX-238;SNX-238
ω-Conotoxin MVIID (SNX-238) is a peptide from the Conus genus that inhibits the ω-Conotoxin-GVIA-sensitive, high-threshold calcium (Ca 2+) current in fish retinal ganglion cells [1].
价 格:¥电议型 号:T80443产 地:中国大陆
-
T77613SNX7;化合物SNX7WAY-323879;WAY-323879
SNX7 (WAY-323879) is an inhibitor of the cell cycle protein-dependent kinase inhibitor (CDKI) pathway. SNX7 can be utilized as a tool for investigating the aging process and other diseases associated with CDKI.
价 格:¥电议型 号:T77613产 地:中国大陆
-
T68393SNX-7081;化合物 SNX-7081SNX-7081
NX-7081 is a novel small molecule inhibitor of Hsp90, which blocks components of inflammation, including cytokine production, protein kinase activity, and angiogenic signaling. SNX-7081 showed strong binding affinity to Hsp90 and expected induction of Hsp70. NF-kappaB nuclear translocation was blocked by SNX-7081 at nanomolar concentrations, and cytokine production was potently inhibited. Growth factor activation of ERK and JNK signaling was significantly reduced by SNX-7081. NO production was a
价 格:¥电议型 号:T68393产 地:中国大陆
-
T6341PF04929113;化合物PF04929113PF-04929113|||SNX-5422|||PF 04929113;PF-04929113|||SNX-5422|||PF 04929113
PF04929113 (SNX-5422) is a synthetic, novel, small molecule Hsp90 Inhibitor. As an oral formulation that demonstrates strong efficacy and tolerability, PF04929113 is positioned as a breakthrough therapy with broad applicability across a wide range of cancers.
价 格:¥电议型 号:T6341产 地:中国大陆
-
T6305SNX2112;化合物SNX2112SNX-2112|||PF 04928473|||SNX 2112;SNX-2112|||PF 04928473|||SNX 2112
SNX2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM.
价 格:¥电议型 号:T6305产 地:中国大陆
-
T4342PF-04929113 Mesylate;化合物PF-04929113 MesylatePF-04929113 (Mesylate)|||SNX-5422 Mesylate;PF-04929113 (
PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37 nM).
价 格:¥电议型 号:T4342产 地:中国大陆
-
T28824SNX0723;化合物SNX0723SNX 0723|||SNX- 0723;SNX 0723|||SNX- 0723
SNX0723 is a potent Hsp90 Inhibitor with anti-Plasmodium activity. SNX0723 shows high binding affinity for HsHsp90 and PfHsp90 with Kis of 4.4 and 47 nM, respectively. SNX0723 inhibits liver-stage P. berghei ANKA parasites with the EC50 of 3.3 μM.
价 格:¥电议型 号:T28824产 地:中国大陆
-
T24811SNX2-1-108;化合物 T24811SNX-21108|||SNX21108|||SNX 21108;SNX-21108|||SNX21108|||SNX 21108
SNX2-1-108 is a selective CDK8 and CDK19 inhibitor.
价 格:¥电议型 号:T24811产 地:中国大陆